DWA
AGN

Douglass Winthrop Advisors’s Allergan plc AGN Stock Holding History

Douglass Winthrop Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,438
Closed -$255K – 248
2020
Q1 		$255K Buy
1,438
+58
+4% +$10.9K 0.01% 210
2019
Q4 		$264K Sell
1,380
-450
-25% -$81.2K 0.01% 239
2019
Q3 		$308K Hold
1,830
– – 0.01% 223
2019
Q2 		$306K Sell
1,830
-597
-25% -$82.7K 0.01% 224
2019
Q1 		$355K Hold
2,427
– – 0.02% 191
2018
Q4 		$324K Hold
2,427
– – 0.02% 196
2018
Q3 		$462K Sell
2,427
-2,000
-45% -$367K 0.02% 177
2018
Q2 		$738K Sell
4,427
-15
-0.3% -$2.41K 0.03% 170
2018
Q1 		$748K Sell
4,442
-395
-8% -$66.3K 0.04% 162
2017
Q4 		$791K Sell
4,837
-7,044
-59% -$1.26M 0.04% 141
2017
Q3 		$2.44M Sell
11,881
-590
-5% -$137K 0.14% 79
2017
Q2 		$3.03M Buy
12,471
+796
+7% +$187K 0.18% 70
2017
Q1 		$2.79M Buy
11,675
+1,574
+16% +$367K 0.17% 69
2016
Q4 		$2.12M Buy
10,101
+1,781
+21% +$369K 0.14% 74
2016
Q3 		$1.92M Buy
8,320
+5,781
+228% +$1.41M 0.13% 80
2016
Q2 		$587K Sell
2,539
-1,200
-32% -$277K 0.04% 144
2016
Q1 		$1M Hold
3,739
– – 0.07% 112
2015
Q4 		$1.17M Buy
3,739
+1,235
+49% +$368K 0.09% 113
2015
Q3 		$681K Sell
2,504
-219
-8% -$67.3K 0.05% 138
2015
Q2 		$810K Hold
2,723
– – 0.06% 140
2015
Q1 		$810K Buy
+2,723
New +$776K 0.06% 140

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Douglass Winthrop Advisors's AGN Position: Q2 2020 in Review

Douglass Winthrop Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,438 shares — an estimated $255K sold.

Douglass Winthrop Advisors first reported a position in AGN in Q1 2015 and held it in 21 quarters. The position peaked at $3.03M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Douglass Winthrop Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Douglass Winthrop Advisors sold 1,438 Allergan plc shares in Q2 2020, an estimated $255K.
  • Douglass Winthrop Advisors first reported a position in Allergan plc in Q1 2015 and held it in 21 quarters.
  • Douglass Winthrop Advisors's Allergan plc position peaked at $3.03M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Douglass Winthrop Advisors's 13F filing for Q2 2020, filed 17 Jul 2020.